1-4 of 4
Mary E DiLorenzo, APN
Close
Sort by
Journal Articles

Prospective Randomized Comparative Study of Myeloablative Fludarabine/Busulfan (Flu/Bu4) and Fludarabine/Busulfan/Total Body Irradiation (Flu/Bu4/TBI) Conditioning Regimen for Patients with Myeloid Diseases

Hyung C. Suh, MDPhD, Scott D. Rowley, MD, Sukhdeep Kaur, MD, Brittany Lukasik, Phyllis McKiernan, Michele Boonstra, APN, Milissa Baker, MSN, ANP, Mary E Dilorenzo, APN, Alan Skarbnik, MD, Themba Nyirenda, PhD, David H. Vesole, MD PhD, Michele L. Donato, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9.
https://doi.org/10.1182/blood-2020-142272
Published: 2020
Journal Articles

Largest Reported Series of Adults Who Received Treatment with Eculizumab (ECU) for Hematopoietic Cell Transplantation-Associated Thrombotic Microangiopathy (TA-TMA). a Single Center Experience

Alan P Skarbnik, MD, Mary E Dilorenzo, APN, Michele Simone, APN, Scott D. Rowley, MD, David H. Vesole, MD PhD, Maribel Pereiras, Pharm D, Tracy Andrews, MSc, Andrew L. Pecora, MD, Michele L. Donato, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3383.
https://doi.org/10.1182/blood-2018-99-113639
Published: 2018
Journal Articles

Preliminary Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (I) and Nivolumab (N) As Consolidation Following Autologous Stem Cell Transplantation (ASCT) for High-Risk Hematologic Malignancies - Cpit-001 Trial

Alan P Skarbnik, MD, Michele L. Donato, MD, Scott D. Rowley, MD, Andre Goy, MD, David H. Vesole, MD, Pashna N. Munshi, MD, David Siegel, MD PhD, Noa Biran, MD, Joshua R Richter, MD, Tatyana A Feldman, MD, Lori A. Leslie, MD, Mary E Dilorenzo, APN, Phyllis McKiernan, APN, MSN, Melissa Baker, MSN, ANP, Michele Boonstra, APN, Michele Simone, APN, Ann McNeill, ANP, Ernest Richards, PhD, Joshua Zenreich, Mariefel Vendivil, RN, Andrea Ortega, RN, Jacquelyn Callahan, RN, Michael B Atkins, MD, Andrew L. Pecora, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 340.
https://doi.org/10.1182/blood.V130.Suppl_1.340.340
Published: 2017
Journal Articles

High Rate of Long Term Complete Remission for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapse after Allogeneic Stem Cell Transplantation and Receive Salvage with Donor Lymphocyte Infusions (DLI)

Alan P Skarbnik, MD, Mary E DiLorenzo, APN, Tracy Andrews, MA, Phyllis McKiernan, APN, Scott D. Rowley, MD, David H. Vesole, MD PhD, Andre Goy, MD, Tatyana Feldman, MD, Lori A Leslie, MD, Lori A. Leslie, MD, Andrew L. Pecora, MD, Michele L. Donato, MD
Journal: Blood
Blood (2016) 128 (22): 5860.
https://doi.org/10.1182/blood.V128.22.5860.5860
Published: 2016